Source: Healio News
A small single-center study published in Kidney International Reports suggests giving bortezomib treatment to patients with multiple myeloma prior to a kidney transplantation to ensure best outcomes.
However, it is still common for patients with multiple myeloma to relapse after kidney transplantation with the treatment.
“Despite treatment with novel agents, a considerable number of patients with multiple myeloma still develop end-stage kidney disease. Long-term dialysis for myeloma patients has significant mortality risk and may prevent them from clinical trials for multiple myeloma